EUVIMEDEUVIMED entdecken
Crossref

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

Tilman Schlothauer, Sylvia Herter, Claudia Ferrara Koller, Sandra Grau-Richards, Virginie Steinhart, Christian Spick, Manfred Kubbies, Christian Klein, Pablo Umaña, Ekkehard Mössner

Protein Engineering Design and Selection · 2016-10 · 29 (10) · 457-466

DOI: 10.1093/protein/gzw040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Engineering Design and Selection, online erschienen am 29.08.2016. Verfasst von Tilman Schlothauer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Protein Analytics, Roche Pharmaceutical Research and Early Development, Large Molecules Research, Roche Innovation Center Penzberg, Non…. Hauptthemen laut MEDLINE: Protein Engineering. Die Arbeit wurde bisher 412-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein EngineeringBinding SitesCell LineConserved SequenceGlycosylationHumansImmunoglobulin Fc FragmentsImmunoglobulin GMembrane GlycoproteinsModels, MolecularMutationPlatelet AggregationPolymorphism, GeneticProtein Structure, SecondaryReceptors, ComplementReceptors, IgG

Stichwörter der Autor:innen

ADCCCDCFc Gamma Receptorseffector silent Fc

Substanzen

FCGR3A protein, humanFc gamma receptor IIBImmunoglobulin Fc FragmentsImmunoglobulin GMembrane GlycoproteinsReceptors, ComplementReceptors, IgGcomplement 1q receptor

Autor:innen und Institutionen

  • Department of Protein Analytics, Roche Pharmaceutical Research and Early Development, Large Molecules Research, Roche Innovation Center Penzberg, Nonnenwald 2, D-82377 Penzberg, Germany.
  • Roche Pharmaceutical Research and Early Development, Large Molecules Research, Roche Innovation Center Zurich, Wagistrasse 18, CH-8952 Schlieren, Switzerland.

Zitieren

APA

Schlothauer, T., Herter, S., Koller, C. F., Grau-Richards, S., Steinhart, V., Spick, C., Kubbies, M., Klein, C., Umaña, P., & Mössner, E. (2016). Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Engineering Design and Selection, 29(10), 457-466. https://doi.org/10.1093/protein/gzw040

Vancouver

Schlothauer T, Herter S, Koller CF, Grau-Richards S, Steinhart V, Spick C, et al. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Engineering Design and Selection. 2016;29(10):457-466. doi:10.1093/protein/gzw040

BibTeX
@article{Schlothauer2016,
  author = {Schlothauer, Tilman and Herter, Sylvia and Koller, Claudia Ferrara and Grau-Richards, Sandra and Steinhart, Virginie and Spick, Christian and Kubbies, Manfred and Klein, Christian and Umaña, Pablo and Mössner, Ekkehard},
  title = {Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions},
  journal = {Protein Engineering Design and Selection},
  year = {2016},
  volume = {29},
  number = {10},
  pages = {457--466},
  doi = {10.1093/protein/gzw040}
}
Kostenlos starten →